Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Egalet says drug less likely to be abused than other painkillers

Written by: | no-reply@reuters.com | Dated: Monday, June 29th, 2015

Egalet Corp said data showed its experimental painkiller was less likely to be abused than a form of morphine already being sold.

A study showed recreational opioid users did not like and were less prone to snort the company’s painkiller, Egalet-001, than MS Contin.

Egalet’s study results come a week before a panel of experts advising the U.S. Food and Drug Administration discuss if reformulated versions of opioids and other painkillers are less likely to be abused.

 

 

(Reporting by Vidya L Nathan in Bengaluru; Editing by Savio D’Souza)


Source: Reuters

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom